Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Eye, Ear & Vision

The Blue Light Hazard Versus Blue Light Hype

The blue light hazard is misused as a marketing stratagem to alarm people into using spectacles and IOLs that restrict blue light. Blue light loss is permanent for pseudophakes with blue-blocking IOLs.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This perspective analyzes clinical, epidemiologic and biophysical data on blue-filtering lenses and the blue light hazard. The authors report that large epidemiologic studies found blue-blocking intraocular lenses did not reduce age-related macular degeneration risk or progression. They argue that the blue light hazard, which refers to very intense exposures, has been misused commercially to promote blue-blocking products.

Limits stated in the abstract
The paper is a perspective that integrates existing data rather than a new systematic analysis, and the abstract does not give participant numbers.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Age-related macular degeneration, Retina, Photoreceptor. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies